UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019136
Receipt number R000022126
Scientific Title Procalcitonin (PCT) levels and postoperative complications in the scheduled surgery patients; a prospective observational study
Date of disclosure of the study information 2015/10/01
Last modified on 2021/04/24 14:06:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Procalcitonin (PCT) levels and postoperative complications in the scheduled surgery patients; a prospective observational study

Acronym

Procalcitonin (PCT) levels in the scheduled surgery patients

Scientific Title

Procalcitonin (PCT) levels and postoperative complications in the scheduled surgery patients; a prospective observational study

Scientific Title:Acronym

Procalcitonin (PCT) levels in the scheduled surgery patients

Region

Japan


Condition

Condition

Scheduled surgery patients

Classification by specialty

Surgery in general Obstetrics and Gynecology Dermatology
Orthopedics Urology Anesthesiology
Oral surgery Neurosurgery Cardiovascular surgery
Plastic surgery Aesthetic surgery Intensive care medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To detect relation between levels of PCT and postoperative complications in scheduled surgery patients depending on operative procedure

Basic objectives2

Others

Basic objectives -Others

To detect influencing factors of levels of PCT

Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison between PCT levels of Day 1 and with or without postoperative complication, depending on operative procedure

Key secondary outcomes

1) Comparison between PCT and other data as for detecting complications
(2) Evaluation of PCT levels according to severity of disease
(3) Analysis of influencing factors of PCT levels
(4) Relation between survival rate (at Day 28, 60, and 90) and PCT level
(5) Time course of changes in PCT levels


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Scheduled surgery patients who candidates surgical ICU admission

Key exclusion criteria

(1) Predict infectious disease before surgery.
(2) Patients who are exposed to infection factor during the operation.
(3) Emergency surgical patients.
(4) Patients who are judged as inappropriate candidates for the trial by the investigators on preoperative anesthetic consultation.

Target sample size

3000


Research contact person

Name of lead principal investigator

1st name Yoshihito
Middle name
Last name Fujita

Organization

Aichi Medical University School of Medicine

Division name

Department of Anesthesiology

Zip code

480-1195

Address

1-1 Karimata Yazako Nagakute, Aichi, 480-1195, Japan

TEL

+81-561-62-3311

Email

fujita.yoshihito.823@mail.aichi-med-u.ac.jp


Public contact

Name of contact person

1st name Yoshihito
Middle name
Last name Fujita

Organization

Aichi Medical University School of Medicine

Division name

Department of Anesthesiology

Zip code

480-1195

Address

1-1 Karimata Yazako Nagakute, Aichi, 480-1195, Japan

TEL

+81-561-62-3311

Homepage URL


Email

fujita.yoshihit.823@mail.aichi-med-u.ac.jp


Sponsor or person

Institute

Aichi Medical University School of Medicine, Department of Anesthesiology

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Aichi Medical University IRB

Address

1-1 Karimata Yazako Nagakute, Aichi, 480-1195, Japan

Tel

+81-561-3311

Email

kanrika@aichi-med-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 10 Month 01 Day


Related information

URL releasing protocol

https://upload.umin.ac.jp/cgi-bin/icdr/ctr_up_reg_f5.cgi

Publication of results

Unpublished


Result

URL related to results and publications

https://upload.umin.ac.jp/cgi-bin/icdr/ctr_up_reg_f5.cgi

Number of participants that the trial has enrolled

1900

Results

Until now on 24 April 2021, we could show these preliminary outcomes. We tried to show the detail outcomes as soon as possible. As for about 1900 patients, the patients with late complications had higher level of procalcitonin (PCT). In addition, the cutoff of 0.5 ng/ml of PCT was useful for detecting the late complications after non-cardiac surgeries.

Results date posted

2021 Year 04 Month 24 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The study was designed as a single-center, prospective, cohort, observational study. All patients scheduled for non-cardiac surgery between December 2015 and March 2017 at our University were screened for the participants.

Participant flow

Before starting to gather patients for inclusion, we picked up optimal surgeries for our study because some surgical procedures do not lead increase of PCT . We chose and investigated the patients of general gastroenterological surgery, thoracic surgery, gynecology, and urology. Therefore, the inclusion criterion was elective general gastroenterological surgery, thoracic surgery, gynecology, and urology. Exclusion criteria comprised: age <18 years, refusal to participate, surgeries suspected of infections, the patients who were exposed to infection factor during the surgery, urgent surgeries and the surgeries except for the upper inclusion surgeries such as cardiac surgery, brain surgery, orthopedic surgery, vascular surgery, breast surgery, cesarean section, endocrine surgery, plastic surgery, ear, nose and throat surgery, and kidney transplant surgery.

Adverse events

This is an observational study. Adverse events were none.

Outcome measures

Until now on 24 April 2021, we could show these preliminary outcomes, briefly. We tried to show the detail outcomes as soon as possible. As for about 1900 patients, the patients with late complications had higher level of procalcitonin (PCT). In addition, the cutoff of 0.5 ng/ml of PCT was useful for detecting the late complications after non-cardiac surgeries.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2015 Year 09 Month 28 Day

Date of IRB

2015 Year 11 Month 24 Day

Anticipated trial start date

2015 Year 12 Month 01 Day

Last follow-up date

2019 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Cohort study
Recruitment: all eligible post-operative patients who were sequentially admitted to the general ICU of Aichi Medical University Hospital for 12 months, from January 2016 to December 2016.
Measurement item: PCT,CRP, WBC, body temperature, postoperative complication and so on.


Management information

Registered date

2015 Year 09 Month 28 Day

Last modified on

2021 Year 04 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022126


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name
2021/04/24 PCT_all_final_data1_eGFR_for_data_depository.xlsx